ILS was recently awarded a contract from the Walter Reed Army Institute of Research to conduct a GLP-compliant in vivo toxicology study evaluating cGMP InvaplexAR-Detox, a potential vaccine for Shigellosis.
ILS was recently awarded a contract from the Walter Reed Army Institute of Research to conduct a GLP-compliant in vivo toxicology study evaluating cGMP InvaplexAR-Detox, a potential vaccine for Shigellosis.